CSI Market
Sign In | Register

Lunai Bioworks Inc (LNAI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access LNAI Annual Cash Flow →
Reviewing cash flow figures over time highlights how Lunai Bioworks Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
9 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-1.55
Depreciation & amortization0.07
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.48
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Accretion Of Discount-
Loss On Forgiveness On Note Receivable-
Gain On Forgiveness Of Debt Related Party-
Change In Consideration Of Contingent Consideration Liability-
Change In Contingent Consideration Liability-
Gain Loss On Sale Of Accounts Receivable-
Change In Unrealized Gain Loss On Fair Value Hedging Instruments-
Non Cash Compensation-
Finance Lease Right Of Use Asset Amortization-
Change In Fair Value Of Contingent Consideration-0.58
Loss On Extinguishment Of Debt-
Restricted Shares For Services Rendered0.27
Amortization Of Discount On Note Payable0.08
Increase Decrease In Operating Lease Liability-0.14
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables-0.07
Increase (Decrease) in Accounts Payable1.42
Increase (Decrease) in Other Accrued Liabilities0.31
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.04
Other Working Capital0.26
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-3.95
Discontinued operations0.00
Net Cash flow from Operating Activities-3.45
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Net Increase In Cash Held In Escrow-
Net Increase Decrease In Cash Held In Escrow-
Payments To Acquire Equity Securities Fv Ni-
Sale Of Equitable Securities0.54
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.54
Financing Activities
Short-term debt Net2.32
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.75
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Expense Paid By Related Party On Behalf Of The Company-
Common Stock Subscribed-
Net Proceeds From Advances To Purchase Common Shares-
Repayment Of Finance Agreement-
Proceeds From Direct Offering Net Of Issuance Costs-
Proceeds From Lpc Equity Agreement-
None-
Repayments Of Finance Agreement-0.58
Proceeds From Atm Offering Net Of Issuance Costs4.50
Proceeds From Subscription Payable-
Repayment Of Notes Payable-1.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities6.00
Effect of exchange rate on cash flow-0.03
Discontinued operations0.00
Free Cash Flow-3.45
Total Cash Flow3.06
4 historic quarters locked

Sign in to unlock the full Lunai Bioworks Inc cash flow history.

Sign In Create Free Account

About Lunai Bioworks Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260331)
  • Filed with the SEC: May 15, 2026
  • Source: e7638_10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001731122-26-000749

Figures are derived from filed reports and may be restated. Historical data is subject to revision.